当前位置:首页 - 行情中心 - 佰仁医疗(688198) - 财务分析 - 现金流量表

佰仁医疗

(688198)

  

流通市值:156.85亿  总市值:156.85亿
流通股本:1.38亿   总股本:1.38亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金307,477,775.9120,772,963.64488,325,313.16285,386,367.89
  收到其他与经营活动有关的现金23,469,946.8717,298,209.3412,321,288.2714,522,845.93
  经营活动现金流入小计330,947,722.77138,071,172.98500,646,601.43299,909,213.82
  购买商品、接受劳务支付的现金24,930,139.0710,486,428.2859,157,812.3830,133,541.08
  支付给职工以及为职工支付的现金85,382,662.446,206,910.8131,624,469.3593,356,820.44
  支付的各项税费53,694,159.329,808,690.2823,061,387.0530,097,057.67
  支付其他与经营活动有关的现金91,657,417.5742,191,600.03150,571,659.24127,243,293.36
  经营活动现金流出小计255,664,378.34128,693,629.39364,415,328.02280,830,712.55
  经营活动产生的现金流量净额75,283,344.439,377,543.59136,231,273.4119,078,501.27
二、投资活动产生的现金流量:
  收回投资收到的现金--6,000,0005,000,000
  取得投资收益收到的现金2,044,049.05328,995.7713,244,633.9312,599,997.71
  处置固定资产、无形资产和其他长期资产收回的现金净额1,028.03-15,375.715,683.28
  收到的其他与投资活动有关的现金536,400,000209,500,0001,010,800,000868,000,000
  投资活动现金流入小计538,445,077.08209,828,995.771,030,060,009.64885,605,680.99
  购建固定资产、无形资产和其他长期资产支付的现金88,933,082.3429,800,617.84163,255,476.67144,692,906.26
  取得子公司及其他营业单位支付的现金--10,835,686.112,000,000
  支付其他与投资活动有关的现金429,300,000169,000,0001,132,200,000804,200,000
  投资活动现金流出小计518,233,082.34198,800,617.841,306,291,162.77960,892,906.26
  投资活动产生的现金流量净额20,211,994.7411,028,377.93-276,231,153.13-75,287,225.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金--14,482,969.6512,981,096.28
  取得借款收到的现金65,000,00025,000,000--
  筹资活动现金流入小计65,000,00025,000,00014,482,969.6512,981,096.28
  分配股利、利润或偿付利息支付的现金110,075,497.56-109,263,392109,263,392
  支付其他与筹资活动有关的现金2,308,344.091,149,906.264,254,053.672,759,591.37
  筹资活动现金流出小计112,383,841.651,149,906.26113,517,445.67112,022,983.37
  筹资活动产生的现金流量净额-47,383,841.6523,850,093.74-99,034,476.02-99,041,887.09
四、汇率变动对现金及现金等价物的影响-4,963.34-56,037.528,032.5-490,746.07
五、现金及现金等价物净增加额48,106,534.1844,199,977.74-239,026,323.24-155,741,357.16
  加:期初现金及现金等价物余额55,549,807.2555,549,807.25294,576,130.49295,740,444.39
  期末现金及现金等价物余额103,656,341.4399,749,784.9955,549,807.25139,999,087.23
补充资料:
  净利润65,459,399.49-132,143,495.69-
  固定资产和投资性房地产折旧12,984,603.12-12,593,894.54-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,984,603.12-12,593,894.54-
  无形资产摊销3,813,606.53-7,152,489.01-
  长期待摊费用摊销2,132,987.28-2,229,186.62-
  处置固定资产、无形资产和其他长期资产的损失-1,753.37--1,095.74-
  固定资产报废损失--50,047.86-
  公允价值变动损失-8,921.33--742,302.66-
  财务费用643,274.2-409,068.52-
  投资损失-4,838,321.34--10,011,207.19-
  递延所得税-2,712,112.86-9,968,559.15-
  其中:递延所得税资产减少-2,263,126.91-9,349,941.99-
    递延所得税负债增加-448,985.95-618,617.16-
  存货的减少-16,468,643.8--17,840,803.93-
  经营性应收项目的减少3,546,911.69--63,035,429.77-
  经营性应付项目的增加9,525,920.39-39,292,236.53-
  其他--18,123,913.04-
  不涉及现金收支的投资和筹资活动金额其他项目--1,285,986.79-
  现金的期末余额103,656,341.43-55,549,807.25-
  减:现金的期初余额55,549,807.25-294,576,130.49-
  现金及现金等价物的净增加额48,106,534.18--239,026,323.24-
公告日期2025-08-282025-04-252025-04-252024-10-30
审计意见(境内)标准无保留意见
TOP↑